Systematic Review of Parotid Gland Sarcomas: Multi-Variate Analysis of Clinicopathologic Findings, Therapeutic Approaches and Oncological Outcomes That Affect Survival Rate.
Colizza A, Di Stadio A, Ralli M, De Luca P, Cavaliere C, Gilardi A, Zoccali F, Riminucci M, Greco A, Corsi A, de Vincentiis M.
Cancers (Basel). 2022 Oct 5;14(19):4862. doi: 10.3390/cancers14194862.
The Diagnosis and Treatment of Solitary Fibrous Tumor of the Parotid Gland.
Wang S, Xing B, Lu Z, Yin D, Yang X, Zhu W.
Ear Nose Throat J. 2025 Jul 30:1455613251362588. doi: 10.1177/01455613251362588. Online ahead of print.
Parotid Gland Tumors: Molecular Diagnostic Approaches.
Vrinceanu D, Dumitru M, Bratiloveanu M, Marinescu A, Serboiu C, Manole F, Palade DO, Costache A, Costache M, Patrascu O.
Int J Mol Sci. 2024 Jul 4;25(13):7350. doi: 10.3390/ijms25137350.
Epithelioid hemangioendothelioma of the parotid salivary gland.
Pigadas N, Mohamid W, McDermott P.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000 Jun;89(6):730-8. doi: 10.1067/moe.2000.106299.
[Case report of epithelioid hemangioendothelioma of the frontal region metastatic to the parotid gland].
Schneider B, ten Cate WJ, Sudermann T, Jahnke K.
Laryngorhinootologie. 1998 Dec;77(12):728-31. doi: 10.1055/s-2007-997232.
[CT features of parotid tumors: an analysis of 133 cases].
Lu YC, Fan WJ, Shen JX, Xiao P.
Ai Zheng. 2007 Nov;26(11):1263-7.
A study of planning dose constraints for treatment of nasopharyngeal carcinoma using a commercial inverse treatment planning system.
Xia P, Lee N, Liu YM, Poon I, Weinberg V, Shin E, Quivey JM, Verhey LJ.
Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):886-96. doi: 10.1016/j.ijrobp.2004.02.040.
Quality assurance for the EORTC 22071-26071 study: dummy run prospective analysis.
Fairchild A, Langendijk JA, Nuyts S, Scrase C, Tomsej M, Schuring D, Gulyban A, Ghosh S, Weber DC, Budach W.
Radiat Oncol. 2014 Nov 26;9:248. doi: 10.1186/s13014-014-0248-9.
A dosimetric comparison of proton and intensity-modulated photon radiotherapy for pediatric parameningeal rhabdomyosarcomas.
Kozak KR, Adams J, Krejcarek SJ, Tarbell NJ, Yock TI.
Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):179-86. doi: 10.1016/j.ijrobp.2008.06.1942. Epub 2008 Nov 18.
Neoadjuvant Checkpoint Inhibitor Therapy for Merkel Cell Carcinoma.
Brohl AS, Sondak VK.
J Clin Oncol. 2020 Aug 1;38(22):2471-2475. doi: 10.1200/JCO.20.00752. Epub 2020 Jun 12.
